Seegene: "Virus-Only Testing May Miss Pneumonia-associated Bacterial Respiratory Pathogens" Calls for a Shift to Comprehensive Syndromic PCR Testing
Virus-only testing may miss pneumonia-associated bacterial co-detections in 78% of virus-positive cases, while bacteria-only testing may miss viral co-detections in 88% of cases positive for pneumonia-associated bacterial pathogens Global Million...
Seegene Launches Industry's First Global Million Clinical Study to Shape New Disease-Specific Testing Standards
Seegene is launching the Global Million Clinical Study at the scale of one million test cases to shape disease-specific testing standards. The study is designed to evaluate the clinical utility of syndromic PCR testing approaches and build...
Seegene Introduces STAgora at ESCMID Global 2026, Highlighting Real-Time Data with Automated PCR Workflows
The company highlights its approach to integrating real-time data analytics with automated PCR infrastructure The standalone booth features STAgora simulation and an interactive touchscreen experience An enhanced CURECA model is presented,...
Seegene Establishes French Subsidiary to Expand European Footprint
- France becomes Seegene's ninth overseas sales subsidiary and third in Europe, following Italy and Germany - The country ranks as Europe's second-largest molecular diagnostics market, driven by demand in sexually transmitted infections and...
Seegene's CURECA(TM) Emerges as a Potential Game Changer in End-to-End PCR Automation
Seegene previews a concept video of CURECATM at ESCMID Global 2025, ahead of its anticipated debut in July With a fully modular design, CURECATM introduces a bold vision for automating pre-treatment across diverse PCR specimen types Developed for...